Sands Capital Ventures
Latest statistics and disclosures from Sands Capital Ventures's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NU, KVYO, DASH, PATH, SNOW, and represent 86.31% of Sands Capital Ventures's stock portfolio.
- Added to shares of these 3 stocks: KVYO (+$78M), CPNG, NU.
- Reduced shares in these 10 stocks: IOT (-$35M), Rayzebio (-$27M), PATH (-$17M), DASH (-$11M), OLK (-$10M), TARS, CRWD, DDOG, CFLT, SNOW.
- Sold out of its positions in CFLT, OLK, Rayzebio.
- Sands Capital Ventures was a net seller of stock by $-26M.
- Sands Capital Ventures has $415M in assets under management (AUM), dropping by 22.67%.
- Central Index Key (CIK): 0001846444
Tip: Access up to 7 years of quarterly data
Positions held by Sands Capital Ventures consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sands Capital Ventures
Sands Capital Ventures holds 20 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Nu Hldgs Ord Shs Cl A (NU) | 26.3 | $109M | 9.2M | 11.93 |
|
|
| Klaviyo Com Ser A (KVYO) | 21.6 | $90M | +648% | 3.5M | 25.48 |
|
| Doordash Cl A (DASH) | 17.4 | $72M | -13% | 523k | 137.72 |
|
| Uipath Cl A (PATH) | 12.6 | $52M | -24% | 2.3M | 22.67 |
|
| Snowflake Cl A (SNOW) | 8.4 | $35M | 216k | 161.60 |
|
|
| 10x Genomics Cl A Com (TXG) | 4.4 | $18M | 482k | 37.53 |
|
|
| Acumen Pharmaceuticals (ABOS) | 3.3 | $14M | 3.4M | 4.05 |
|
|
| Acrivon Therapeutics Common Stock (ACRV) | 2.8 | $12M | 1.7M | 7.15 |
|
|
| Tarsus Pharmaceuticals (TARS) | 1.5 | $6.2M | -34% | 170k | 36.35 |
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.5 | $2.1M | 725k | 2.87 |
|
|
| 908 Devices (MASS) | 0.4 | $1.8M | 237k | 7.55 |
|
|
| Candel Therapeutics (CADL) | 0.3 | $1.3M | 812k | 1.58 |
|
|
| Spruce Biosciences (SPRB) | 0.1 | $622k | 787k | 0.79 |
|
|
| Absci Corp (ABSI) | 0.1 | $328k | 58k | 5.68 |
|
|
| Coupang Cl A (CPNG) | 0.1 | $212k | +41% | 12k | 17.79 |
|
| Toast Cl A (TOST) | 0.0 | $148k | -16% | 5.9k | 24.92 |
|
| Samsara Com Cl A (IOT) | 0.0 | $135k | -99% | 3.6k | 37.79 |
|
| Datadog Cl A Com (DDOG) | 0.0 | $126k | -25% | 1.0k | 123.60 |
|
| Crowdstrike Hldgs Cl A (CRWD) | 0.0 | $89k | -67% | 279.00 | 320.59 |
|
| Gitlab Class A Com (GTLB) | 0.0 | $38k | 658.00 | 58.32 |
|
Past Filings by Sands Capital Ventures
SEC 13F filings are viewable for Sands Capital Ventures going back to 2021
- Sands Capital Ventures 2024 Q1 filed May 14, 2024
- Sands Capital Ventures 2023 Q3 filed Nov. 14, 2023
- Sands Capital Ventures 2023 Q2 filed Aug. 15, 2023
- Sands Capital Ventures 2023 Q1 filed May 12, 2023
- Sands Capital Ventures 2022 Q4 filed Feb. 13, 2023
- Sands Capital Ventures 2022 Q3 filed Nov. 9, 2022
- Sands Capital Ventures 2022 Q2 filed Aug. 12, 2022
- Sands Capital Ventures 2022 Q1 filed May 13, 2022
- Sands Capital Ventures 2021 Q4 filed Jan. 21, 2022
- Sands Capital Ventures 2021 Q3 restated filed Nov. 12, 2021
- Sands Capital Ventures 2021 Q3 filed Nov. 4, 2021